Stay updated on Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial page.

Latest updates to the Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check18 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating restricted access. The visible elements include the standard ClinicalTrials.gov header and footer, signaling an access issue rather than a data update.SummaryDifference20%

- Check67 days agoChange DetectedThe page now displays a new site revision label, Revision: v3.6.6, replacing the previous Revision: v3.6.5, which appears to reflect a system update rather than a modification to the study details.SummaryDifference0.1%

Stay in the know with updates to Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase I Study DS-2741a in Atopic Dermatitis Clinical Trial page.